XML 38 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Accounts Receivable, Allowance for Credit Loss, Current $ 5 $ 5
Finite-Lived Intangible Assets, Accumulated Amortization 434 385
Loans and Leases Receivable, Allowance 26 26
Other Noncurrent Assets, Allowance 51 23
Non Recourse Debt Current 1,758 1,367
Non Recourse Debt Non Current $ 17,846 $ 13,603
Preferred Stock, Shares Authorized 50,000,000  
Preferred Stock, Shares Issued 1,043,050  
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 1,200,000,000 1,200,000,000
Common stock, shares issued (in shares) 818,790,001 818,717,043
Common stock, shares outstanding (in shares) 668,743,464 666,793,625
Treasury Stock, Common, Shares 150,046,537 151,923,418
Preferred stock (without par value, 50,000,000 shares authorized; 1,043,050 issued and outstanding at December 31, 2022 and December 31, 2021) $ 838 $ 838
Common stock ($0.01 par value, 1,200,000,000 shares authorized; 818,790,001 issued and 668,743,464 outstanding at December 31, 2022 and 818,717,043 issued and 666,793,625 outstanding at December 31, 2021) 8 8
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Loans and Leases Receivable, Allowance 26 26
Consolidated Variable Interest Entities [Member]    
Non Recourse Debt Current 416 302
Non Recourse Debt Non Current 2,295 2,223
Accounts Receivable    
Accounts Receivable, Allowance for Credit Loss, Current $ 3 $ 9